Quantcast

Latest Joslin Diabetes Center Stories

2010-07-30 14:41:28

Individualized care necessary for diabetic patients with kidney failure Aggressive blood sugar control does not improve survival in diabetic patients with kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society Nephrology (CJASN). The results suggest that physicians should individualize blood sugar targets for these patients and not rely on recommendations based on studies in the general population. Uncontrolled blood sugar levels...

2010-07-29 11:00:00

CLEVELAND, July 29 /PRNewswire/ -- With diabetes affecting the lives of hundreds of thousands of people throughout Ohio and Pennsylvania, Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical prescription holders. (Logo: http://photos.prnewswire.com/prnh/20100729/NE42933LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20100729/NE42933LOGO ) The program, which...

2010-07-29 11:00:00

PITTSBURGH, July 29 /PRNewswire/ -- With diabetes affecting the lives of hundreds of thousands of people throughout Pennsylvania and Ohio, Giant Eagle®, Inc. has announced that it will begin offering five commonly prescribed medications for the treatment of type 2 diabetes at no cost to medical prescription holders. (Logo: http://photos.prnewswire.com/prnh/20100729/NE42933LOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20100729/NE42933LOGO ) The program, which...

2010-07-27 01:17:17

The drug rimonabant was developed as a treatment for obesity and its myriad of serious health consequences (for example, type 2 diabetes). Despite having its desired effects on weight, which it decreased, and on levels of glucose and fats in the blood, rimonabant was never approved for use in the US because of serious neurological side effects including depression and anxiety. Now, a team of researchers, led by George Kunos, at the National Institutes of Health, Bethesda, and Alexandros...

2010-07-12 07:39:00

Today, July 12, Noon-1:30 EDT, Rayburn House Office Building, Room B-338 WASHINGTON, July 12 /PRNewswire-USNewswire/ -- Fifty-seven million Americans with pre-diabetes are teetering on the brink of developing one of the most damaging and costly diseases of our time. Yet research is showing that sound, low-cost solutions can help pull them back from a diagnosis of full-blown diabetes. At 57 million, the number of people with pre-diabetes is more than double that of people who currently...

2010-06-30 13:24:45

In high-risk adults with type 2 diabetes, researchers have found that two therapies may slow the progression of diabetic retinopathy, an eye disease that is the leading cause of vision loss in working-age Americans. Intensive blood sugar control reduced the progression of diabetic retinopathy compared with standard blood sugar control, and combination lipid therapy with a fibrate and statin also reduced disease progression compared with statin therapy alone. However, intensive blood pressure...

2010-06-30 08:33:44

Advances in treatment and care have reduced overall death rates from type 1 diabetes, with women and African-Americans having higher risks of mortality, according to a University of Pittsburgh Graduate School of Public Health study being presented at the 70th Scientific Sessions of the American Diabetes Association. The results, abstract number 0326-OR, are based on the Allegheny County Type 1 Diabetes Registry, one of the largest population-based registries of the disease, which includes...

2010-06-17 12:33:00

SAN DIEGO, June 17 /PRNewswire/ -- Profil(TM) Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today the appointment of Prof. Dr. Lutz Heinemann as Director of Scientific Services and Robert J. Schott, MD, MPH, FACC as Director of Cardiometabolic Research. Prof. Dr. Heinemann will oversee the scientific aspects of Profil's integrated approach from clinical trial protocol design to the publication of study...

2010-06-16 15:49:00

JDRF Volunteer, Philanthropist, Former Internet Executive to Lead Top Funder of Cures and Treatments for People with Type 1 Diabetes and Its Complications NEW YORK, June 16 /PRNewswire-USNewswire/ -- The Juvenile Diabetes Research Foundation, a leader in type 1 diabetes research worldwide, announced today that Jeffrey Brewer has been named President and Chief Executive Officer. Mr. Brewer, an entrepreneur and philanthropist, has been a passionate JDRF volunteer and donor for the past...

2010-06-14 08:00:00

RIDGEFIELD, Conn., June 14 /PRNewswire/ -- A new game called HealthSeeker(TM) launched today to more than 400 million active users of Facebook®(1), with the goal of helping adults with specific lifestyle and nutritional challenges. While the benefits of the game are available to anyone, HealthSeeker specifically helps people with diabetes make more informed lifestyle decisions in an innovative way that complements their daily use of social media. To view the multimedia...


Word of the Day
virgule
  • A punctuation mark (/) used to separate related items of information.
  • A little rod; a twig.
This word comes from the Late Latin 'virgula,' accentual mark, a diminutive of 'virga,' rod.
Related